常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.31/--
|
|
企業價值
482.07M
|
| 資產負債 |
|
每股賬面淨值
3.56
|
| 現金流量 |
|
現金流量率
0.12
|
| 損益表 |
|
收益
448.27M
|
|
每股收益
3.23
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its products include vaccines for hepatitis A, hepatitis B, EV-A71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella, mumps, and tetanus. The Company generates maximum revenue from Mainland China. |

-- 
